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Five Nations Health and Justice 
Collaboration 
Summary 
The Five Nations Health and Justice Collaboration is a forum for discussion and debate, 
providing a collective authoritative voice on health and wellbeing, and health and social 
care for people in contact with the criminal justice system (CJS), in settings across 
England, Scotland, Wales, Northern Ireland and the Republic of Ireland. The 
collaboration aims to facilitate the sharing of best practice, mutual learning and 
improved collective capability of health and justice partners in the five nations as well as 
informing the work of the UK Collaborating Centre for the WHO Health in Prisons 
Programme. 
 
The Five Nations Health and Justice Collaboration has been sharing increasing reports 
of NPS use in prisons across the five nations and their impact, not only on the health of 
the individual but also the prison regime, which has led to us making this collective 
statement.  
 
We welcome feedback on this work and ask that any comments are sent to 
health&justice@phe.gov.uk  
Background 
The European drug marketplace has become increasingly complex. An increasing 
number of new substances are available alongside more established drugs and diverted 
medications. Polydrug use patterns have become the norm among those experiencing 
drug problems1. The United Nations Office for Drugs and Crime (UNODC) World Drug 
Report 20162 states that between 2008 and 2015, a total of 644 new psychoactive 
substances (NPS) had been reported by 102 countries and territories to the UNODC 
early warning advisory on NPS.  
 
In 2015 the Chief Inspector for Prisons in England and Wales described new 
psychoactive substances as “the most serious threat to the safety and security of jails” 
and called for urgent development and rolling out of more effective drug testing methods 
enabling the prison service to respond to changing drug misuse patterns quickly and 
flexibly3.  
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Evidence suggests that users of new psychoactive substances are at risk of a number 
of physical, psychological and behavioural adverse effects on health. As well as 
negative effects on the criminal justice system an increased burden is being felt on NHS 
resources, in particular emergency services, primary care and mental health services4. 
 
The Five Nations Health and Justice Collaboration has identified NPS as a particular 
area of concern from increasing cases in prisons across the UK and Republic of Ireland 
and would therefore like to raise awareness of this current health and justice challenge.  
Prevalence 
There is a lack of evidence in relation to substance misuse trends in prisons however 
changing patterns of drug use in the community provide a useful context for 
understanding drug misuse in prisons2. The Crime Survey for England and Wales 
(2014-15) stated use of NPS in the previous year was concentrated among young 
adults aged 16-24. Of these, 84% who had used an NPS had also used another illicit 
drug in the last year5. Men were significantly more likely to have used NPS than women, 
with young men aged 16-24 around four times more likely to have used an NPS than all 
adults aged 16 to 595,6. Herbal smoking mixtures were most commonly used, followed 
by powders, crystals, tablets and other substances. The least commonly used form of 
substances were liquids.  
 
The National Records of Scotland’s publication of Drug Related Deaths7 (2016) showed 
there were 706 drug related deaths registered in Scotland in 2015, 93 more than in 
2014. NPS were present in 112 of these deaths, and implicated in 74. NPS were the 
only substances present in 3 out of the 74 deaths where NPS was implicated. The 
number of deaths where NPS was present in the body has increased from just four in 
2009 when the first Scottish deaths involving NPS were registered. 
 
In Northern Ireland there is evidence of community NPS use reported amongst 2-11% 
of drug users8. The All Ireland Drug Prevalence Survey 2014/15 states 3.8% of the 
Northern Ireland population reported having ever used an NPS. Usage was highest 
amongst males aged 15-34 years9. 
 
The 2014 EuroFlash Barometer report on Young People and Drugs surveyed 13,000 
15-24 year olds of which 22% of the Irish respondants had used NPS at least once, the 
highest use being in the last year and in Ireland10.  
 
Within samples from Welsh prisons submitted to WEDINOS the most commonly 
identified substances were the synthetic cannabinoid receptor agonists; 5F-PB-22 and 
5F-AKB48 in the form of ready to smoke plant matter4. 
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Views from people in prison 
The 2015 Scottish Prison Service Survey, undertaken in all 15 Scottish prisons and with 
a 55% response rate, indicated that 27% of respondents claimed to have used NPS 
prior to prison. Of these respondents 60% claimed to have used synthetic cannabinoids, 
60% claimed to have used stimulants and 31% claimed to have used hallucinogens. 
The survey also asked prisoners to report on NPS usage while in prison, with 11% of 
respondents claiming to have done so. Of these respondents 82% claimed to have used 
synthetic cannabinoids, 42% stimulants and 31% hallucinogens11. 
 
In 2016, NHS England commissioned a consultation with over 600 people in nine 
prisons on NPS use in custody12. The consultation suggested that of the people who 
used substances in prison, one in three were using NPS. The negative impact reported 
by prisoners included increasing addiction, debt and violence amongst prisoners and 
poorer mental and physical health outcomes, which then exacerbated bullying and 
violence. The report recommended that substance misuse services in prisons needed to 
reconsider their approach with an increased focus on peer support services.  
Recommendations 
• clinical management plans for prisoners under the influence of NPS would support 
practitioners and should be developed in collaboration with the prison clinical leads, 
local emergency department, ambulance service and custodial provider 
• the development of systems to monitor drug problems and patterns of use in prison, 
including diverted medications, will be paramount in understanding the scope of the 
challenges, to inform both health and security policy and operational responses 
• staff working in prisons would benefit from appropriate training on the 
clinical/symptom management of NPS and appropriate harm reduction advice 
• future research should focus on NPS use in prison including substance use trends 
in prisons, operational impact on the prison and the individual’s experience of using 
NPS in prison, as well as rigorously evaluating programmes to tackle NPS use in 
prisons 
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